Obesity hypoventilation syndrome
Open accessThe DOI matches its Crossref record; 229 of the 229 references it cites were found in a registry or an index.
Abstract
Obesity hypoventilation syndrome (OHS) is defined as a combination of obesity (body mass index ≥30 kg·m −2 ), daytime hypercapnia (arterial carbon dioxide tension ≥45 mmHg) and sleep disordered breathing, after ruling out other disorders that may cause alveolar hypoventilation. OHS prevalence has been estimated to be ∼0.4% of the adult population. OHS is typically diagnosed during an episode of acute-on-chronic hypercapnic respiratory failure or when symptoms lead to pulmonary or sleep consultation in stable conditions. The diagnosis is firmly established after arterial blood gases and a sleep study. The presence of daytime hypercapnia is explained by several co-existing mechanisms such as obesity-related changes in the respiratory system, alterations in respiratory drive and breathing abnormalities during sleep. The most frequent comorbidities are metabolic and cardiovascular, mainly heart failure, coronary disease and pulmonary hypertension. Both continuous positive airway pressure (CPAP) and noninvasive ventilation (NIV) improve clinical symptoms, quality of life, gas exchange, and sleep disordered breathing. CPAP is considered the first-line treatment modality for OHS phenotype with concomitant severe obstructive sleep apnoea, whereas NIV is preferred in the minority of OHS patients with hypoventilation during sleep with no or milder forms of obstructive sleep apnoea (approximately <30% of OHS patients). Acute-on-chronic hypercapnic respiratory failure is habitually treated with NIV. Appropriate management of comorbidities including medications and rehabilitation programmes are key issues for improving prognosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![FIGURE 4 Positive airway pressure adjustment in acute decompensated obesity-related respiratory failure. The adjustment of continuous positive airway pressure/expiratory positive airway pressure (EPAP) has the objective of eliminating obstructive events, snoring and intermittent oxygen desaturations. Adjustments in inspiratory positive airway pressure (IPAP) are aimed at eliminating hypoventilation and sustained hypoxaemia. For both EPAP and IPAP, the pressure should increase progressively until attaining the objectives (resolution of upper airway obstructive events and sleep hypoventilation) or until the maximal tolerated pressure is reached. Alternatively, EPAP/continuous positive airway pressure can be adjusted to eliminate obstructive apnoeas and IPAP can be further increased to eliminate obstructive hyponoeas, snoring and hypoventilation. With this strategy, the patient may require lower EPAP and therefore achieve higher levels of pressure support in order to improve hypoventilation [96]. Supplemental oxygen is habitually added to positive airway pressure therapy when an adequate oxygenation level is not achieved despite adequate titration of positive airway pressure therapy. NIV: noninvasive ventilation; PaO2: arterial oxygen tension; SaO2: arterial oxygen saturation.](https://figures.cochat.ai/paper-figures/ef1d7d1269d84daba2323b3faaab95fb/obesity-hypoventilation-syndrome-figure-4.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The prevalence of OHS in the general population is unknown, but conservative estimates range between 0.15% and 0.4% amongst adults in the US.82,83”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [83]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In contrast to isolated OSA, patients with obesity hypoventilation syndrome, which is characterized by awake hypercapnia (Paco 2 >45 mm Hg) and obesity, commonly develop moderate to severe PH and higher risk of adverse outcomes, including cor pulmonale and death.45”
From Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart Association (2021) · cites this paper as [45]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevalence of Childhood and Adult Obesity in the United States, 2011-2012
Ogden, C. L., Carroll, M. D., Kit, B. K., & Flegal, K. M. (2014) · JAMA · doi:10.1001/jama.2014.732 · Cited by 8,072
Serum Immunoreactive-Leptin Concentrations in Normal-Weight and Obese Humans
Considine, R. V., Sinha, M. K., Heiman, M. L., Kriauciunas, A., Stephens, T. W., Nyce, M. R., Ohannesian, J. P., Marco, C. C., McKee, L. J., Bauer, T. L., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602013340503 · Cited by 6,326
Berry, R. B., Budhiraja, R., Gottlieb, D. J., Gozal, D., Iber, C., Kapur, V. K., Marcus, C. L., Mehra, R., Parthasarathy, S., Quan, S. F., et al. (2012) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.2172 · Cited by 5,302
Marin, J. M., Carrizo, S. J., Vicente, E., & Agusti, A. G. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71141-7 · Cited by 4,678
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457
Excess Deaths Associated With Underweight, Overweight, and Obesity
Flegal, K. M. (2005) · JAMA · doi:10.1001/jama.293.15.1861 · Cited by 2,824
Sleep Disordered Breathing and Mortality: Eighteen-Year Follow-up of the Wisconsin Sleep Cohort
(2008) · Sleep · doi:10.5665/sleep/31.8.1071 · Cited by 1,853
Sleep-Disordered Breathing and Mortality: A Prospective Cohort Study
Punjabi, N. M., Caffo, B. S., Goodwin, J. L., Gottlieb, D. J., Newman, A. B., O'Connor, G. T., Rapoport, D. M., Redline, S., Resnick, H. E., Robbins, J. A., et al. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000132 · Cited by 1,482
Perioperative safety in the longitudinal assessment of bariatric surgery
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901836 · Cited by 1,392
Objective Measurement of Patterns of Nasal CPAP Use by Patients with Obstructive Sleep Apnea
Kribbs, N. B., Pack, A. I., Kline, L. R., Smith, P. L., Schwartz, A. R., Schubert, N. M., Redline, S., Henry, J. N., Getsy, J. E., & Dinges, D. F. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/147.4.887 · Cited by 1,339
Cited by
Yeghiazarians, Y., Jneid, H., Tietjens, J. R., Redline, S., Brown, D. L., El-Sherif, N., Mehra, R., Bozkurt, B., Ndumele, C. E., Somers, V. K., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000988 · Cited by 1,431
Ahmed, S. K., & Mohammed, R. A. (2025) · Metabolism Open · doi:10.1016/j.metop.2025.100375 · Cited by 432
“Treatment of OHS generally focuses on the use of PAP therapy, often in conjunction with attempts at weight management, as symptoms can be considerably improved with weight loss [206].”
International Consensus Statement on Obstructive Sleep Apnea
Chang, J. L., Goldberg, A. N., Alt, J. A., Mohammed, A., Ashbrook, L., Auckley, D., Ayappa, I., Bakhtiar, H., Barrera, J. E., Bartley, B. L., et al. (2023) · International Forum of Allergy & Rhinology · doi:10.1002/alr.23079 · Cited by 350
Self-citationRubino, F., Cohen, R. V., Mingrone, G., le Roux, C. W., Mechanick, J. I., Arterburn, D. E., Vidal, J., Alberti, G., Amiel, S. A., Batterham, R. L., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30157-1 · Cited by 174
Sleep-related breathing disorders and pulmonary hypertension
Adir, Y., Humbert, M. J. C., & Chaouat, A. (2020) · European Respiratory Journal · doi:10.1183/13993003.02258-2020 · Cited by 167
Metadata
- Authors
- Masa, J. F., Pépin, J.-L., Borel, J.-C., Mokhlesi, B., Murphy, P. B., & Sánchez-Quiroga, M. Á.
- Affiliations
- Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (ES)
- Inserm (FR)
- University of Chicago (US)
- King's College London (GB)
- Corresponding author
- Masa, Juan F.
- ORCID
- Venue
- European Respiratory Review
- Publisher
- European Respiratory Society (ERS)
- Published
- 2019-03-14
- Volume
- 28
- Issue
- 151
- Pages
- 180097
- ISSN
- 0905-9180 (ISSN-L)
- 1600-0617
- PMC
- PMC9491327
- OpenAlex
- W2144702261
- Cited by
- 360
- References
- 228
- Citations by year
- 2026: 45 · 2025: 66 · 2024: 50 · 2023: 65 · 2022: 57 · 2021: 37 · 2020: 29 · 2019: 7
- FWCI
- 3.82
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- Locations
- European Respiratory Review (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Obstructive Sleep Apnea Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Respiratory Support and Mechanisms
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroscience of respiration and sleep
- Keywords
- obesity hypoventilation syndrome, hypercapnia, alveolar hypoventilation, sleep-disordered breathing, obstructive sleep apnea, hypercapnic respiratory failure, continuous positive airway pressure, non-invasive ventilation, comorbidities, heart failure, pulmonary hypertension, arterial blood gases, polysomnography
- MeSH terms
- Adult, Female, Humans, Hypercapnia, Lung, Male, Middle Aged, Obesity, Obesity Hypoventilation Syndrome, Quality of Life, Pulmonary Ventilation, Risk Factors, Body Mass Index, Treatment Outcome, Recovery of Function, Continuous Positive Airway Pressure, Noninvasive Ventilation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Obesity hypoventilation syndrome. https://app.cochat.ai/papers/10.1183/16000617.0097-2018
- The paper
- Masa, J. F., Pépin, J.-L., Borel, J.-C., Mokhlesi, B., Murphy, P. B., & Sánchez-Quiroga, M. Á. (2019). Obesity hypoventilation syndrome. European Respiratory Review. https://doi.org/10.1183/16000617.0097-2018
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.